The macroeconomic impact of non-communicable diseases in China and India: Estimates, projections, and comparisons

Journal of the Economics of Ageing

Volumn 4, Issue , 2014, Pages 100-111

  Bloom, David E ^a   Cafiero Fonseca, Elizabeth T ^a   McGovern, Mark E ^a,b   Prettner, Klaus ^c   Stanciole, Anderson ^d   Weiss, Jonathan ^e,f   Bakkila, Samuel ^a   Rosenberg, Larry ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD CENTER FOR POPULATION AND DEVELOPMENT STUDIES   (United States)

^c VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^d BILL AND MELINDA GATES FOUNDATION   (United States)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNICEF   (United States)

Author keywords

Cost benefit analysis; Economic growth; Health and economic development; Non communicable disease

Indexed keywords

EID: 84914820549     PISSN: 2212828X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jeoa.2014.08.003     Document Type: Article

References (85)

1. Abegunde D., Stanciole A. An Estimation of the Economic Impact of Chronic Noncommunicable Diseases in Selected Countries 2006, World Health Organization, Department of Chronic Diseases and Health Promotion.
2. Abegunde D.O., Mathers C.D., Adam T., et al. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007, 370(9603):1929-1938.
3. Abel A.B., Mankiw N.G., Summers L.R., et al. Assessing dynamic efficiency: theory and evidence. Rev. Econ. Stud. 1989, 56(January):1-20.
4. Aghion P., Howitt P. A model of growth through creative destruction. Econometrica 1992, 60(2):323-351.
5. Baja, V., 2012. India's poor to benefit from free drugs; Government to propose distribution of generics, a blow to big companies, International Herald Tribune.
6. Barro R.J., Sala-i-martin X. Convergence. J. Political Economy 1992, 100(2):223-251.
7. Becker G.S., Philipson T.J., Soares R.R. The quantity and quality of life and the evolution of world inequality. Am. Econ. Rev. 2005, 95(1):277-291. 10.2307/4132680.
8. Bloom D.E., Canning D., Sevilla J. The effect of health on economic growth: a production function approach. World Dev. 2004, 32(1):1-13. 10.1016/j.worlddev.2003.07.002.
9. Bloom D.E., Canning D., Hu L., et al. The contribution of population health and demographic change to economic growth in China and India. J. Comp. Econ. 2010, 38(1):17-33. 10.1016/j.jce.2009.11.002.
10. Bloom D.E. 7 billion and counting. Science 2011, 333(6042):562-569. 10.1126/science.1209290.
11. Bloom D.E., Cafiero E.T., Jané-Llopis E., et al. The Global Economic Burden of Noncommunicable Diseases 2011, World Economic Forum, Geneva.
12. Bloom D.E., Chisholm D., Jané-Llopis E., et al. From Burden to "Best Buys": Reducing the Economic Impact of Non-Communicable Diseases in Low- and Middle-Income Countries 2011, World Economic Forum, Geneva.
13. Bloom D.E., Canning D., Fink G. Disease and development revisited. J. Political Economy 2014, (forthcoming).
14. Bloom D.E., Fink G. The economic case for devoting public resources to health. Manson's Tropical Diseases 2014, 23-30. Elsevier. 23rd ed.
15. Centers for Disease Control and Prevention, 2013. Smoking and tobacco use: bidis and kreteks. Retrieved from: http://www.cdc.gov/tobacco/data_statistics/fact_sheets/tobacco_industry/bidis_kreteks/.
16. Currie G., Dymond Kerfoot K., Donaldson C., et al. Are cost of injury studies useful?. Inj. Prev. 2000, 6:175-176.
17. Dey S., Nambiar D., Lakshmi J.K., et al. Health of the elderly in India: challenges of access and affordability. Aging in Asia: Findings from New and Emerging Data Initiatives 2012, 371-386. National Academies Press, Washington, DC. P. Smith, M. Majmundar (Eds.).
18. Dudeja V., Misra A., Pandey R.M., et al. BMI does not accurately predict overweight in Asians in northern India. Br. J. Nutr. 2001, 86:105-112.
19. Dwyer D.S., Mitchell O.S. Health problems as determinants of retirement: are self-rated measures endogenous?. J. Health Econ. 1999, 18(2):173-193. 10.1016/S0167-6296(98)00034-4.
20. Express News Service, 2013. Karnataka becomes 26th state to ban gutkha, The New Indian Express. Retrieved from http://newindianexpress.com/states/karnataka/Karnataka-becomes-26th-state-to-ban-gutkha/2013/06/01/article1615107.ece.
21. Evans J.M., Kiran P.R., Bhattacharyya O.K. Activating the knowledge-to-action cycle for geriatric care in India. Health Res. Policy Syst. 2011, 9:42. 10.1186/1478-4505-9-42.
22. Ferlay, J., Shin, H.R., Bray, F., et al., 2013. GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC cancer base no. 10 [Internet]. Lyon, France: international agency for research on cancer. Retrieved from: http://globocan.iarc.fr,%20accessed%20on%202/7/13.
23. Gao S., Zheng R., Hu T. Can increases in the cigarette tax rate be linked to cigarette retail prices? Solving mysteries related to the cigarette pricing mechanism in China. Tob. Control 2012, 21:560-562.
24. Giovino G.A., Mirza S.A., Samet J.M., et al. Tobacco use in 3billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012, 380:668-679.
25. Goel S., Ravindra K., Singh R.J., et al. Effective smoke-free policies in achieving a high level of compliance with smoke-free law: experiences from a district of North India. Tob. Control 2013, 1-4. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/23322311.
26. Grossman G.M., Helpman E. Quality ladders in the theory of economic growth. Rev. Econ. Stud. 1991, 58(1):43-61.
27. Gu D., Reynolds K., Wu X., et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension 2002, 40(6):920-927. Retrieved from: http://hyper.ahajournals.org/cgi/doi/10.1161/01.HYP.0000040263.94619.D5.
28. Howitt P. Steady endogenous growth with population and R&D inputs growing. J. Political Economy 1999, 107(4):715-730.
29. Institute for Health Metrics and Evaluation, 2013a. Global Burden of Disease Country Profiles: China. Retrieved from: . http://www.healthmetricsandevaluation.org/sites/default/files/country-profiles/GBD%20Country%20Report%20-%20China.pdf.
30. Institute for Health Metrics and Evaluation, 2013b. Global Burden of Disease Country Profiles: India. Retrieved from: http://www.healthmetricsandevaluation.org/sites/default/files/country-profiles/GBD%20Country%20Report%20-%20India.pdf.
31. Institute for Health Metrics and Evaluation China Global Burden of Disease Study 2010 (GBD 2010) Results 1990-2010 2013, Institute for Health Metrics and Evaluation (IHME), Seattle, United States.
32. Institute for Health Metrics and Evaluation India Global Burden of Disease Study 2010 (GBD 2010) Results 1990-2010 2013, Institute for Health Metrics and Evaluation (IHME), Seattle, United States.
33. International Institute for Population Sciences, 2005-2006. National Family Health Survey (NFHS-3). Retrieved from: http://pdf.usaid.gov/pdf_docs/PNADK385.pdf.
34. Jamison D.T., Summers L.H., Alleyne G., et al. Global health 2035: a world converging within a generation. Lancet 2013, 382(9908):1898-1955.
35. John, R.M., Rao, R.K., Rao, M.G., et al., 2010. The economics of tobacco and tobacco taxation in India. Retrieved from: http://global.tobaccofreekids.org/files/pdfs/en/India_tobacco_taxes_report_en.pdf.
36. Jones C.I. R&D-based models of economic growth. J. Political Economy 1995, 103(4):759-783.
37. Jones C.I. Sources of U.S. economic growth in a world of ideas. Am. Econ. Rev. 2002, 92(1):220-239.
38. Kaldor N. A model of economic growth. Econ. J. 1957, 67(268):591-624.
39. Kearney P.M., Whelton M., Reynolds K., et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365(9455):217-223. 10.1016/s0140-6736(05)17741-1.
40. Keller W. International Trade, Foreign Direct Investment, and Technological Spillovers (Working Paper No. 15442) 2009, National Bureau of Economic Research, Cambridge, MA.
41. Liu B.Q., Peto R., Chen Z.M., et al. Emerging tobacco hazards in China 1. Retrospective proportional mortality study of one million deaths. BMJ 1998, 317(7170):1411.
42. Lopez-Casasnovas G., Rivera B., Currais L. Health and Economic Growth: Findings and Policy Implications 2005, MIT Press, Cambridge, MA.
43. Lozano R., Naghavi M., Foreman K., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2095-2128.
44. Lucas R. On the mechanics of economic development. J. Monetary Econ. 1988, 22(1):3-42.
45. Ma J., Apelberg B.J., Avila-Tang E., et al. Workplace smoking restrictions in China: results from a six county survey. Tob. Control 2010, 19(5):403-409.
46. Mankiw N.G., Romer D., Weil D.N. A contribution to the empirics of economic growth. Q. J. Econ. 1992, 107(2):407-437.
47. Marrero S.L., Bloom D.E., Adashi E.Y. Noncommunicable diseases: a global health crisis in a new world order. J. Am. Med. Assoc. 2012, 307(19):2037-2038.
48. McGarry K. Health and retirement: do changes in health affect retirement expectations?. J. Hum. Resour. 2004, 39(3):624.
49. McQuinn K., Whelan K. Conditional convergence and the dynamics of the capital-output ratio. J. Econ. Growth 2007, 12(2):159-184.
50. Mendis S. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull. World Health Organiz. 2007, 85(4):279-288. Retrieved from: http://www.who.int/bulletin/volumes/85/4/06-033647.pdf.
51. Ministry of Health and Family Welfare Bidi Smoking and Public Health 2008, Ministry of Health and Family Welfare, Government of India, New Delhi.
52. Murray C.J.L., Ezzati M., Flaxman A.D., et al. GBD 2010: design, definitions, and metrics. Lancet 2012, 380(9859):2063-2066. 10.1016/S0140-6736(12)61899-6.
53. Murray C.J., Vos T., Lozano R., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380(9859):2197-2223.
54. National Sample Survey Organisation Morbidity, Health Care and the Condition of the Aged. National Sample Survey, 60th Round, (Report no. 507 (60/25.0/1) 2006, Ministry of Statistics and Programme, New Delhi.
55. Parasuraman S., Kishor S., Singh S.K., et al. A Profile of Youth in India. National Family Health Survey (NFHS-3) 2005, International Institute for Population Sciences, Mumbai.
56. Parente S.L., Prescott E.C. Barriers to technology adoption and development. J. Political Economy 1994, 102(2):298-321.
57. Peretto P.F. Technological change and population growth. J. Econ. Growth 1998, 3(4):283-311.
58. Popkin B.M., Horton S., Kim S., et al. Trends in diet, nutritional status, and diet-related noncommunicable diseases in China and India: the economic costs of the nutrition transition. Nutr. Rev. 2001, 59(12):379-390. Retrieved from: http://www.ncbi.nlm.nih.gov/pubmed/11766908.
59. Press Information Bureau, 2013. Health Warnings on Tobacco Products.[Pictorial/Graphic.ID:95088]. New Delhi: Government of India. Available from: http://pib.nic.in/newsite/erelease.aspx?relid=95088.
60. Rice D.P. Cost of illness studies: what is good about them?. Inj. Prev. 2000, 6:177-179.
61. Romer P. Endogenous technological change. J. Political Economy 1990, 98(5):71-102.
62. Salomon J.A., Wang H., Freeman M.K., et al. Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet 2012, 380(9859):2144-2162.
63. Segerstrom P.M. Endogenous growth without scale effects. Am. Econ. Rev. 1998, 88(5):1290-1310.
64. Singha, K., 2012. Government to bring essential medicines under price control, The Times of India.
65. Solow R.M. A contribution to the theory of economic growth. Q. J. Econ. 1956, 70(1):65-94.
66. Song Z., Storsletten K., Zilibotti F. Growing Like China. Am. Econ. Rev. 2011, 101:196-233.
67. Strauss J., Hong H., Lei X., et al. Healthcare and insurance among the elderly in China: evidence from the CHARLS pilot. Aging in Asia: Findings from New and Emerging Data Initiatives 2012, 342-370. National Academies Press, Washington, DC. P. Smith, M. Majmundar (Eds.).
68. Strulik H. The role of human capital and population growth in the theory of economic growth. Rev. Int. Econ. 2005, 13(1):129-145.
69. United Nations, Department of Economic and Social Affairs, Population Division, 2013. World Population Prospects: The 2012 Revision, http://esa.un.org/unpd/wpp/index.htm.
70. Van Mourik M.S., Cameron A., Ewen M., et al. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovas. Disord. 2010, 10(1):25. Retrieved from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898673&tool=pmcentrez&rendertype=abstract.
71. Viscusi W.K., Aldy J.E. The value of a statistical life: a critical review of market estimates throughout the world. J. Risk Uncertainty 2003, 27(1):5-76.
72. Wan X., Ma S., Hoek J., et al. Conflict of interest and FCTC implementation in China. Tob. Control 2012, 21:412-415.
73. Weil D. Endemic diseases and African economic growth: challenges and policy responses. J. Afr. Econ. 2010, 19(AERC Supplement 3):iii81-iii109. 10.1093/jae/ejq018.
74. The World Bank World Development Report 1993: Investing in Health 1993, Oxford University Press, New York.
75. The World Bank World Development Indicators 2014, The World Bank, Washington, DC, Retrieved from: http://databank.worldbank.org/data/views/variableSelection/selectvariables.aspx?source=world-development-indicators.
76. World Health Organization Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health 2001, World Health Organization, Geneva.
77. World Health Organization The Global Burden of Disease: 2004 Update 2008, World Health Organization, Geneva.
78. World Health Organization WHO Guide to Identifying the Economic Impact of Disease and Injury 2009, World Health Organization, Geneva.
79. World Health Organization Global Status Report on Alcohol and Health 2011 2011, World Health Organization, Geneva.
80. World Health Organization Global Status Report on Noncommunicable Diseases 2010 2011, World Health Organization, Geneva.
81. World Health Organization WHO NCD Country Profiles 2011, World Health Organization, Geneva.
82. World Health Organization Graph Illustration of Percentage of all NCD Deaths Occurring Under the Age of 70, 2008 2011, WHO Global Health Observatory, Retrieved from: http://gamapserver.who.int/gho/interactive_charts/ncd/mortality/premature/atlas.html.
83. World Health Organization Scaling up Action Against Noncommunicable Diseases: How much will it Cost? 2011, World Health Organization, Geneva.
84. Yang, D.T., Zhang, J., Zhou S., 2011. Why are saving rates so high in China? NBER Working Paper No. 16771.
85. Zhao Y., Park A., Strauss J., et al. Challenges of Population Aging in China: Evidence from the National Baseline Survey of the China Health and Retirement Longitudinal Study (CHARLS) 2013, National School of Development, Peking University, Beijing.